Contact UsInvestorsCareersMediaContact Us
Investor Relations

Statutory Communications 2021 - 2022

Pfizer Limited Notice for closure of Trading Window – December 31, 2021

Notice of the Board Meeting – February 3, 2022

Resignation of Mr. R. A. Shah as an Independent Director

Pfizer Limited Notice for closure of Trading Window – March 31, 2022

Pfizer Limited – Annual Secretarial Compliance Report

Sale of Pfizer Limited’s Upjohn Business to Mylan Pharmaceuticals Private Limited

Pfizer Limited Notice for closure of Trading Window – September 30, 2021

Pfizer Limited – Proceedings of the 70th Annual General Meeting

Stock Exchanges Intimation – 70th AGM – remote e-voting results

Pfizer Limited Notice of 70th Annual General Meeting and general information - Business Standard and Sakaal​​​​​​​

Important Communication for Shareholders

Pfizer Limited Annual Report and 70th Annual General Meeting & Book Closure Notice

Notice of the Board Meeting – July 28, 2021

Pfizer Limited Notice for closure of Trading Window – June 30, 2021

Disclosure on Related Party Transactions as on March 31, 2021

About UsOur PeopleOur Community EffortsOur ProductsInvestorsCareerMediaAdverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2021 Pfizer Inc. All rights reserved.